ACET
Adicet Bio, Inc.Company Information
- Company Name
- Adicet Bio, Inc.
- CIK
- CIK0001720580
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- ACET: Nasdaq
- Fiscal Year End
- December 26
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- ACET
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-02-20
- Last sale
- 2026-04-08
- Shares purchased (TTM)
- 5,074,751
- Shares sold (TTM)
- 72,939
Institutional Sentiment
- As of
- 2026-03-31
- Institutional shares owned
- 6,224,573
- Shares outstanding
- 10,744,621
- Ownership
- 57.93%
Earnings Market Reaction
- Filing date
- 2026-08-05
- Price on filing date
- —
- 1-month reaction
- -1.09%
- 3-month reaction
- Pending
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 33 | 36 | 39 | 29 | 35 | 28 | 56 | 105 | 224 | 160 | 160 | 183 | ||||||
| Short Term Investments | - | - | - | - | - | - | - | 97 | - | - | - | - | ||||||
| Other Short Term Investments | 85 | 101 | 120 | 74 | 90 | 122 | 120 | - | - | - | 0 | - | ||||||
| Prepaid Expense And Other Assets Current | 3 | 2 | 2 | 3 | 3 | 3 | 4 | 4 | 4 | 3 | 3 | 3 | ||||||
| Assets Current | 121 | 140 | 161 | 106 | 128 | 154 | 180 | 206 | 228 | 250 | 162 | 186 | ||||||
| Goodwill | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Finance Lease Right Of Use Asset | 1 | 1 | 1 | 1 | - | - | 0 | - | - | - | - | - | ||||||
| Restricted Cash Noncurrent | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 0 | 0 | 0 | 0 | - | ||||||
| Property Plant And Equipment Net | 14 | 15 | 17 | 18 | 20 | 21 | 23 | 24 | 24 | 25 | 27 | 28 | ||||||
| Operating Lease Right Of Use Asset | 10 | 10 | 11 | 12 | 13 | 13 | 14 | 15 | 16 | 17 | 17 | 18 | ||||||
| Other Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | ||||||
| Assets | 148 | 169 | 192 | 140 | 163 | 191 | 220 | 246 | 269 | 293 | 207 | 233 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 4 | 3 | 5 | 4 | 3 | 4 | 5 | 3 | 2 | 3 | 3 | 4 | ||||||
| Accrued Liabilities And Other Liabilities | 12 | 12 | 14 | 11 | 11 | 9 | 11 | 14 | 13 | 12 | 13 | 13 | ||||||
| Operating Lease Liability Current | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | ||||||
| Finance Lease Liability Current | 0 | 0 | 0 | 0 | - | - | 0 | - | - | - | - | - | ||||||
| Liabilities Current | 18 | 18 | 22 | 19 | 17 | 16 | 19 | 19 | 18 | 17 | 19 | 20 | ||||||
| Operating Lease Liability Noncurrent | 9 | 10 | 11 | 12 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | ||||||
| Finance Lease Liability Noncurrent | 1 | 1 | 1 | 1 | - | - | 0 | - | - | - | - | - | ||||||
| Other Liabilities Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities | 28 | 29 | 33 | 31 | 30 | 30 | 34 | 34 | 34 | 34 | 37 | 39 | ||||||
Stockholders Equity | ||||||||||||||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital Common Stock | 777 | 775 | 774 | 693 | 691 | 688 | 684 | 681 | 674 | 668 | 551 | 546 | ||||||
| Retained Earnings Accumulated Deficit | -656 | -635 | -615 | -584 | -557 | -526 | -498 | -469 | -439 | -409 | -381 | -351 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -0 | -0 | 0 | 0 | -0 | -0 | 0 | 0 | - | - | 0 | - | ||||||
| Stockholders Equity | 120 | 140 | 159 | 109 | 133 | 161 | 187 | 212 | 235 | 259 | 170 | 195 | ||||||
| Liabilities And Stockholders Equity | 148 | 169 | 192 | 140 | 163 | 191 | 220 | 246 | 269 | 293 | 207 | 233 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 150 | 150 | 150 | ||||||
| Common Stock Shares Issued | 9 | 10 | 10 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 3 | 3 | ||||||
| Shares Outstanding | 9 | 10 | 10 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 3 | 3 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialAdicet Bio, Inc. (ACET) — SEC Financial Statements & Analysis
Adicet Bio, Inc. (ACET) is a pharmaceutical preparations company, incorporated in DE. Adicet Bio, Inc. trades on Nasdaq as: ACET. Adicet Bio, Inc. (ACET)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-05. Based on that filing, Adicet Bio, Inc. carries a market cap of $92.84M, a P/E ratio of -0.94x, a P/B ratio of 0.77x, an enterprise value of $60.51M, and an EV/EBITDA multiple of -0.63x. On profitability, it posts a Return on Equity (ROE) of -78.08%, a Return on Assets (ROA) of -63.62%, and a Return on Invested Capital (ROIC) of -112.84%. Per share, it reports EPS of $-9.21, diluted EPS of $-9.21, free cash flow per share of $-7.91, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of -16.57% year-over-year and EPS growth of -55.80% year-over-year. On the balance sheet, it maintains a current ratio of 6.71x, a quick ratio of 6.57x, working capital of $102.76M, a debt-to-equity ratio of 0.23x, a debt ratio of 0.19, an interest coverage ratio of -1280.35x, free cash flow of $-84.99M (TTM), and net debt of $-32.33M. Figures sourced from SEC EDGAR.
- Market Cap
- $92.84M
- P/E TTM
- -0.94x
- EPS TTM
- $-9.21
- P/B TTM
- 0.77x
- ROE TTM
- -78.08%
- ROA TTM
- -63.62%
- Debt To Equity
- 0.23x
- Free Cash Flow TTM
- $-84.99M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Adicet Bio, Inc. in?
Adicet Bio, Inc. (ACET) operates in the Pharmaceutical Preparations industry.
What exchange does ACET trade on?
Adicet Bio, Inc. (ACET) trades on the Nasdaq.
Where is Adicet Bio, Inc. incorporated?
Adicet Bio, Inc. is incorporated in DE.
When was Adicet Bio, Inc. (ACET)'s most recent SEC filing?
Adicet Bio, Inc. (ACET)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-05.
What is ACET's market cap?
Adicet Bio, Inc. (ACET) has a market capitalization of $92.84M as of 2026-06-30.
What is ACET's EPS (earnings per share)?
Adicet Bio, Inc. (ACET)'s trailing twelve month EPS is $-9.21 as of 2026-06-30.
What is ACET's ROE (return on equity)?
Adicet Bio, Inc. (ACET)'s trailing twelve month Return on Equity (ROE) is -78.08% as of 2026-06-30.
What is ACET's ROA (return on assets)?
Adicet Bio, Inc. (ACET)'s trailing twelve month Return on Assets (ROA) is -63.62% as of 2026-06-30.
What is ACET's ROIC (return on invested capital)?
Adicet Bio, Inc. (ACET)'s trailing twelve month Return on Invested Capital (ROIC) is -112.84% as of 2026-06-30.
What is ACET's EV/EBITDA?
Adicet Bio, Inc. (ACET)'s trailing twelve month EV/EBITDA is -0.63x as of 2026-06-30.